The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 12 2021
Historique:
received: 14 01 2021
accepted: 16 11 2021
entrez: 7 12 2021
pubmed: 8 12 2021
medline: 11 1 2022
Statut: epublish

Résumé

Histology plays an essential role in therapeutic decision-making for lung cancer patients. However, the molecular determinants of lung cancer histology are largely unknown. We conduct whole-exome sequencing and microarray profiling on 19 micro-dissected tumor regions of different histologic subtypes from 9 patients with lung cancers of mixed histology. A median of 68.9% of point mutations and 83% of copy number aberrations are shared between different histologic components within the same tumors. Furthermore, different histologic components within the tumors demonstrate similar subclonal architecture. On the other hand, transcriptomic profiling reveals shared pathways between the same histologic subtypes from different patients, which is supported by the analyses of the transcriptomic data from 141 cell lines and 343 lung cancers of different histologic subtypes. These data derived from mixed histologic subtypes in the setting of identical genetic background and exposure history support that the histologic fate of lung cancer cells is associated with transcriptomic features rather than the genomic profiles in most tumors.

Identifiants

pubmed: 34873156
doi: 10.1038/s41467-021-27341-1
pii: 10.1038/s41467-021-27341-1
pmc: PMC8648877
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7081

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA070907
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234629
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009666
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Nat Genet. 2017 Jan 31;49(2):170-174
pubmed: 28138153
Cell. 2018 Apr 19;173(3):581-594.e12
pubmed: 29656895
J Clin Pathol. 1994 Aug;47(8):711-3
pubmed: 7962622
Ann Thorac Surg. 2013 Apr;95(4):1189-95
pubmed: 23473060
Ann Oncol. 2015 Jan;26(1):64-70
pubmed: 25319062
Eur J Cardiothorac Surg. 2002 Nov;22(5):701-7
pubmed: 12414033
Lancet Oncol. 2016 Jul;17(7):883-895
pubmed: 27269741
Arch Pathol Lab Med. 2013 Jan;137(1):32-40
pubmed: 22583114
Nat Commun. 2021 Dec 6;12(1):7081
pubmed: 34873156
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13790-5
pubmed: 11707567
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Science. 2014 Oct 10;346(6206):256-9
pubmed: 25301631
Genome Biol. 2020 Nov 4;21(1):271
pubmed: 33148332
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
Am J Surg Pathol. 2002 Sep;26(9):1184-97
pubmed: 12218575
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Bioinformatics. 2004 Feb 12;20(3):307-15
pubmed: 14960456
Genome Biol. 2014;15(12):550
pubmed: 25516281
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Am J Clin Pathol. 2011 May;135(5):783-9
pubmed: 21502435
Nat Commun. 2016 Oct 21;7:13200
pubmed: 27767028
Onco Targets Ther. 2018 Aug 14;11:4829-4835
pubmed: 30147334
Nature. 2019 Dec;576(7785):112-120
pubmed: 31748746
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Arch Pathol Lab Med. 2018 Aug;142(8):914-921
pubmed: 30040455
Nat Genet. 2016 Jun;48(6):607-16
pubmed: 27158780
Nat Methods. 2014 Apr;11(4):396-8
pubmed: 24633410
J Thorac Oncol. 2017 Aug;12(8):1257-1267
pubmed: 28535939
Bioinformatics. 2010 Oct 1;26(19):2363-7
pubmed: 20688976
J Thorac Oncol. 2011 Jan;6(1):195-8
pubmed: 21178714
Nat Commun. 2019 Jul 5;10(1):2978
pubmed: 31278276
Cancer Lett. 1995 Sep 25;96(2):163-8
pubmed: 7585452
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Nat Genet. 2012 Oct;44(10):1104-10
pubmed: 22941188
Mod Pathol. 2018 Jun;31(6):947-955
pubmed: 29410488
Commun Biol. 2018 Mar 22;1:20
pubmed: 30271907
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
Genome Med. 2018 Apr 25;10(1):33
pubmed: 29695279
Clin Lung Cancer. 2019 Jan;20(1):30-36.e3
pubmed: 30279110
Nat Rev Clin Oncol. 2015 Sep;12(9):511-26
pubmed: 25963091
J Clin Oncol. 2017 Sep 10;35(26):3065-3074
pubmed: 28498782
J Thorac Oncol. 2015 Aug;10(8):1133-41
pubmed: 26039012
Nat Commun. 2018 Mar 13;9(1):1048
pubmed: 29535388
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
N Engl J Med. 2018 Dec 6;379(23):2220-2229
pubmed: 30280641
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Br J Cancer. 2014 Sep 9;111(6):1222-9
pubmed: 25051406
Bioinformatics. 2017 Sep 15;33(18):2938-2940
pubmed: 28645171
Nat Commun. 2015 Mar 11;6:6377
pubmed: 25758528
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
Cancer. 2007 Feb 1;109(3):581-7
pubmed: 17186532
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Clin Cancer Res. 2010 Oct 1;16(19):4864-75
pubmed: 20643781
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
Semin Diagn Pathol. 2014 Jul;31(4):271-7
pubmed: 25002356
J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472
pubmed: 31805526
J Mol Diagn. 2015 Jan;17(1):53-63
pubmed: 25468433
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Thorac Surg Clin. 2014 Aug;24(3):257-66
pubmed: 25065926
Nat Genet. 2014 Mar;46(3):225-233
pubmed: 24487277
Clin Cancer Res. 2020 Feb 15;26(4):892-901
pubmed: 31694833

Auteurs

Ming Tang (M)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Hussein A Abbas (HA)

Medical Oncology Fellowship, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Marcelo V Negrao (MV)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Maheshwari Ramineni (M)

Department of Pathology, Baylor College of Medicine, Houston, TX, 77030, USA.

Xin Hu (X)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Shawna Marie Hubert (SM)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Junya Fujimoto (J)

Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Alexandre Reuben (A)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Susan Varghese (S)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Jianhua Zhang (J)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Jun Li (J)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Chi-Wan Chow (CW)

Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Xizeng Mao (X)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Xingzhi Song (X)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Won-Chul Lee (WC)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Jia Wu (J)

Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Latasha Little (L)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Curtis Gumbs (C)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Carmen Behrens (C)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Cesar Moran (C)

Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Annikka Weissferdt (A)

Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

J Jack Lee (JJ)

Department of Biostatistics, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Boris Sepesi (B)

Department of Thoracic Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Stephen Swisher (S)

Department of Thoracic Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Chao Cheng (C)

Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, 77030, USA.

Jonathan Kurie (J)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Don Gibbons (D)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

John V Heymach (JV)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Ignacio I Wistuba (II)

Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

P Andrew Futreal (PA)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. AFutreal@mdanderson.org.

Neda Kalhor (N)

Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. nkalhor@mdanderson.org.

Jianjun Zhang (J)

Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jzhang20@mdanderson.org.
Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jzhang20@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH